Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Ortho-McNeil's delta-opioid receptor ligands have broad therapeutic potential

Aug. 10, 1999

NMDA antagonist NPS-1392 is a candidate for treatment of ischemic stroke

Aug. 9, 1999

Role of cannabinoid receptors in L-dopa-induced dyskinesia

Aug. 9, 1999

L-Dopa-induced dyskinesia in primates is reduced significantly by coadministration of (-)-OSU-6162

Aug. 9, 1999

Novel AMPA/NMDA antagonists discovered at Rhone-Poulenc Rorer

Aug. 5, 1999

NIH researchers identify potential clue to the prevention of prion diseases

Aug. 5, 1999

Guilford and Amgen begin clinical testing of neuroimmunophilins

Aug. 5, 1999

Guilford continues research into NAALDase inhibitors

Aug. 4, 1999

Celgene receives patent, completes trial enrollment for ADD/ADHD product

Aug. 4, 1999

MorphiDex not approvable, FDA says

Aug. 4, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...